Percutaneous coronary intervention
Transforming complex PCI procedures into confident care with Philips solutions
Demonstrated results
28.8%
reduction in contrast agent with Dynamic Coronary Roadmap2
Clinical Study: Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial.
85%
of users believe the Azurion TSM control of HEMO visualizations & measurements improves workflow5
$896
saved per patient with Philips iFR compared to FFR.3
Featured products for percutaneous coronary intervention
Azurion 7 M12 - the heart of our solution for cardiac care
Proven to reduce procedure time by 17%1 by experiencing the outstanding performance of the Azurion 7 M12. This industry-leading image-guided solution supports better patient care and operational efficiency with seamless control from a single tableside touch screen for fast, informed decisions in the sterile field.
Dynamic Coronary Roadmap - find your path
Find the right path and improve PCI outcomes. This Philips exclusive solution offers motion-compensated, real-time navigational guidance of coronary arteries and reduces contrast agent by 28.8%2
Hemo with IntelliVue X3 - monitor anywhere
Improve productivity to meet growing demand for cath lab procedures. This solution simplifies workflow by bringing advanced hemodynamic measurements to the cath lab. Integrated with the IntelliVue X3 patient monitor, it enables continuous patient monitoring throughout the cath lab.
IntraSight - when every tiny move matters
Manage care with confidence. The IntraSight platform is where imaging, physiology, co-registration* and software come together. Clearly identify coronary and peripheral artery disease, and optimize treatment plans with a platform designed to meet the evolving needs of your lab today and tomorrow.
“Dynamic Coronary Roadmap is a great asset to add to the interventional toolkit. It is an easy to use tool which reduces the contrast exposure to patients. It is very useful in patients with low GFR or patients with branch vessel disease. I use it very frequently to assist in decreasing contrast use. “
Dr. Strobel,
Interventional Cardiologist
Baptist Health, Little Rock, US
Documentation
- Brochure
-
Related procedures
-
![TAVR / TAVI procedures]()
Solutions for TAVR and TAVI procedures offered by Philips image-guided therapy.
-
![Left atrial appendage occlusion (LAAO)]()
Solutions for Left Atrial Appendage Occlusion (LAAO) procedures offered by Philips image-guided therapy.
-
![Mitral and tricuspid therapies]()
Solutions for mitral valve interventions offered by Philips image-guided therapy.
-
![Cardiac surgery in the Hybrid OR]()
Our leading imaging systems, advanced clinical tools and devices enable surgeons as they decide, guide, treat, and confirm results.
-
![Congenital Heart Disease Interventions]()
Philips image guided solutions for congenital heart disease interventions
Technologies and innovations
-
Image-guided therapy solutions portfolio integrates best in class imaging systems and software, with diagnostic and therapeutic devices to support complex procedures.
-
![Coronary IVUS - Intravascular Ultrasound]()
Learn how Philips intravascular ultrasound (IVUS) imaging offers advanced visualization that enables you to tailor your treatment for every patient.
-
![Clinically proven Azurion with ClarityIQ technology]()
Providing superb image quality at ultra-low dose settings.
-
![Azurion]()
Philips Azurion is the next generation image-guided therapy platform with a unique user experience to help you optimize the performance of your cath lab.
Footnotes
[1] Philips whitepaper 12nc 4522 991 30501; Reduction of procedure time by 17% with Philips Azurion in independently verified study; www.philips.com/ healthcare/resources/landing/azurion/lab-performance-study-results. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. [2] Clinical Study: Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial. [3] Gotberg M, et al. Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. Int J Cardiol 2021 1;344:54-59. [4] Co-registration tools available within InstraSight 7 configuration via SyncVision. [5] Results obtained during usability study performed in December 2016. The study involved 33 participants. Participants were spread evenly over technologist/ nurses and physicians. To evaluate benefits of the multi-user capabilities of the new system design and user satisfaction, its novel design was tested by participants that had relevant working experience in the interventional lab and who had not previously used the new system. Data on File.
Always read the label and follow the directions for use. Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device. Products subject to country availability. Please contact your local sales representative. ©2024 Koniklijke Philips N.V. All rights reserved. Trademarks are the property of Koninklijke Philips N.V. or their respective owners. Philips reserves the right to change product specifications without prior notification.
